ELISE BIOTECH LTDActive

Company number 12424248Private limited companyIncorporated 2020

Key figures

£20,274+26.8%
Net assets 2025/26
-16.2%
Average annual change 2020/21–2025/26
020 k40 k60 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, ELISE BIOTECH LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Total assets50,21345,79842,81233,24823,209
Total liabilities55,69754,63754,91249,23643,483
Net assets / total equity5,4848,83912,10015,98820,274
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ELISE BIOTECH LTD

Company

ELISE BIOTECH LTD is a private limited company registered with Companies House under company number 12424248. It was incorporated on 24 Jan 2020. Its status is active. The registered office is in Broadstairs (CT10). Its nature of business (SIC 2007) is manufacture of homogenized food preparations and dietetic food (10860), manufacture of other food products n.e.c. (10890), manufacture of basic pharmaceutical products (21100), research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Jan 2026); the company files micro-entity accounts. Net assets were £20,274, up 26.8% on the previous year. Total assets were £23,209 and total liabilities £43,483. The company had an average of 1 employee. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Oct 2027. The next confirmation statement is due by 6 Feb 2027.